Few studies have examined the role of PSMA PET/CT in the detection of intraprostatic radiorecurrent cancer, and only 4 have validated findings histologically.15 Of these, only patients with a positive PET/CT were biopsied, and PET/CT interpretation criteria were not consistent. This evidence concerns the gene FOLH1 and cancer.